[Club drugs]
- PMID: 22525626
[Club drugs]
Abstract
Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used by adolescents and young adults, mostly in recreational settings like dance clubs and rave parties. These drugs have diverse psychotropic effects, are associated with several degrees of toxicity, dependence and long term adverse effects. Some have been used for several decades, while others are relatively recent substances of abuse. They have distinct pharmacodynamic and pharmacokinetic properties, are not easy to detect and, many times, the use of club drugs is under diagnosed. Although the use of these drugs is increasingly common, few health professionals feel comfortable with the diagnosis and treatment. The authors performed a systematic literature review, with the goal of synthesising the existing knowledge about club drugs, namely epidemiology, mechanism of action, detection, adverse reactions and treatment. The purpose of this article is creating in Portuguese language a knowledge data base on club drugs, that health professionals of various specialties can use as a reference when dealing with individual with this kind of drug abuse.
Comment in
-
[Club drugs].Acta Med Port. 2012 Jan-Feb;25(1):60; author reply 60. Epub 2012 May 25. Acta Med Port. 2012. PMID: 22883253 Portuguese. No abstract available.
Similar articles
-
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.Am J Health Syst Pharm. 2002 Jun 1;59(11):1067-76. doi: 10.1093/ajhp/59.11.1067. Am J Health Syst Pharm. 2002. PMID: 12063892 Review.
-
Club drugs: coming to a patient near you.Nurse Pract. 2014 Mar 13;39(3):20-5; quiz 25-6. doi: 10.1097/01.NPR.0000443227.72357.72. Nurse Pract. 2014. PMID: 24481485
-
Club drugs: reasons for and consequences of use.J Psychoactive Drugs. 2004 Sep;36(3):295-302. doi: 10.1080/02791072.2004.10400030. J Psychoactive Drugs. 2004. PMID: 15559677
-
Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.Am Fam Physician. 2004 Jun 1;69(11):2619-26. Am Fam Physician. 2004. PMID: 15202696 Review.
-
Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.Drug Alcohol Depend. 2006 Sep 1;84(1):102-13. doi: 10.1016/j.drugalcdep.2006.01.002. Epub 2006 Feb 17. Drug Alcohol Depend. 2006. PMID: 16483730 Free PMC article.
Cited by
-
"K-Powder" Exposure during Adolescence Elicits Psychiatric Disturbances Associated with Oxidative Stress in Female Rats.Pharmaceuticals (Basel). 2022 Nov 9;15(11):1373. doi: 10.3390/ph15111373. Pharmaceuticals (Basel). 2022. PMID: 36355545 Free PMC article.
-
Evaluation of Cytotoxic, Necrotic, Apoptotic, and Autophagic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine on U-87 MG (Glial) and B104-1-1 (Neuronal) Cell Lines.Neurotox Res. 2022 Oct;40(5):1499-1515. doi: 10.1007/s12640-022-00543-1. Epub 2022 Jul 15. Neurotox Res. 2022. PMID: 35838908
-
A New Psychoactive Substance, Gamma Hydroxybutyrate (GHB): A Case Report.Noro Psikiyatr Ars. 2019 Jul 16;56(3):229-231. doi: 10.29399/npa.23198. eCollection 2019 Sep. Noro Psikiyatr Ars. 2019. PMID: 31523153 Free PMC article.
-
"Special K" Drug on Adolescent Rats: Oxidative Damage and Neurobehavioral Impairments.Oxid Med Cell Longev. 2019 Mar 14;2019:5452727. doi: 10.1155/2019/5452727. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31001375 Free PMC article.
-
Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence: A randomized, double-blind, placebo-controlled trial.Medicine (Baltimore). 2016 Jul;95(28):e4135. doi: 10.1097/MD.0000000000004135. Medicine (Baltimore). 2016. PMID: 27428201 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous